Jyothy Labs Share Price
Sector: Personal & Household Prods.
382.00 +5.90 (1.57%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
369.40
Today’s High
388.00
52 Week Low
268.05
52 Week High
595.00
381.00 +4.30 (1.14%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
374.65
Today’s High
388.95
52 Week Low
300.10
52 Week High
595.85
Key Metrics
- Market Cap (In Cr) 14027.6
- Beta 0.79
- Div. Yield (%) 0.93
- P/B 7.65
- TTM P/E 39.16
- Peg Ratio 1.63
- Sector P/E 0
- Open Price 369.4
- Prev Close 376.1
Jyothy Labs Analysis
Price Analysis
-
1 Week0.31%
-
3 Months2.21%
-
6 Month-22.65%
-
YTD-5.14%
-
1 Year-11.72%
Risk Meter
- 39% Low risk
- 39% Moderate risk
- 39% Balanced Risk
- 39% High risk
- 39% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 6
- 5
- 5
- 5
- Buy
- 3
- 3
- 3
- 2
- Hold
- 1
- 2
- 2
- 2
- Sell
- 0.00
- 0.00
- 0.00
- 1
- Strong Sell
- 1
- 1
- 1
- 1
- Total
- 11
- 11
- 11
- 11
Jyothy Labs News
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy
2 min read . 03 Feb 2025Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy
2 min read . 29 Jan 2025Diwali 2024 Stock Picks: Top 10 stocks to buy for Samvat 2081 by HDFC Securities
5 min read . 16 Oct 2024Jyothy Labs Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 2756.93
- Selling/ General/ Admin Expenses Total
- 780.1
- Depreciation/ Amortization
- 49.96
- Other Operating Expenses Total
- 45.07
- Total Operating Expense
- 2327.09
- Operating Income
- 429.84
- Net Income Before Taxes
- 478.84
- Net Income
- 369.45
- Diluted Normalized EPS
- 9.77
- Period
- 2024
- Total Assets
- 2400.93
- Total Liabilities
- 592.62
- Total Equity
- 1808.31
- Tangible Book Valueper Share Common Eq
- 27.68
- Period
- 2024
- Cashfrom Operating Activities
- 457.92
- Cashfrom Investing Activities
- -344.37
- Cashfrom Financing Activities
- -134.81
- Net Changein Cash
- -21.26
- Period
- 2023
- Total Revenue
- 2486.02
- Selling/ General/ Admin Expenses Total
- 661.01
- Depreciation/ Amortization
- 50.12
- Other Operating Expenses Total
- 31.25
- Total Operating Expense
- 2213.18
- Operating Income
- 272.83
- Net Income Before Taxes
- 299.22
- Net Income
- 239.73
- Diluted Normalized EPS
- 5.98
- Period
- 2023
- Total Assets
- 2061.71
- Total Liabilities
- 512.72
- Total Equity
- 1548.99
- Tangible Book Valueper Share Common Eq
- 20.6
- Period
- 2023
- Cashfrom Operating Activities
- 328.6
- Cashfrom Investing Activities
- -48.29
- Cashfrom Financing Activities
- -250.68
- Net Changein Cash
- 29.64
- Period
- 2022
- Total Revenue
- 2196.49
- Selling/ General/ Admin Expenses Total
- 598.1
- Depreciation/ Amortization
- 58.17
- Other Operating Expenses Total
- 28.62
- Total Operating Expense
- 2006.19
- Operating Income
- 190.29
- Net Income Before Taxes
- 196.92
- Net Income
- 161.97
- Diluted Normalized EPS
- 4.38
- Period
- 2022
- Total Assets
- 2022.78
- Total Liabilities
- 579.22
- Total Equity
- 1443.57
- Tangible Book Valueper Share Common Eq
- 17.79
- Period
- 2022
- Cashfrom Operating Activities
- 202.56
- Cashfrom Investing Activities
- -31.71
- Cashfrom Financing Activities
- -166.69
- Net Changein Cash
- 4.16
- Period
- 2021
- Total Revenue
- 1909.12
- Selling/ General/ Admin Expenses Total
- 529.53
- Depreciation/ Amortization
- 55.59
- Other Operating Expenses Total
- 18.01
- Total Operating Expense
- 1673.37
- Operating Income
- 235.75
- Net Income Before Taxes
- 234.63
- Net Income
- 199.45
- Diluted Normalized EPS
- 5.96
- Period
- 2021
- Total Assets
- 1955.99
- Total Liabilities
- 527.44
- Total Equity
- 1428.55
- Tangible Book Valueper Share Common Eq
- 17.36
- Period
- 2021
- Cashfrom Operating Activities
- 402.16
- Cashfrom Investing Activities
- -129.12
- Cashfrom Financing Activities
- -216.1
- Net Changein Cash
- 56.94
- Period
- 2020
- Total Revenue
- 1711.17
- Selling/ General/ Admin Expenses Total
- 500.46
- Depreciation/ Amortization
- 52.92
- Other Operating Expenses Total
- 19.79
- Total Operating Expense
- 1516.46
- Operating Income
- 194.71
- Net Income Before Taxes
- 181.51
- Net Income
- 170.34
- Diluted Normalized EPS
- 4.74
- Period
- 2020
- Total Assets
- 1836.19
- Total Liabilities
- 607.55
- Total Equity
- 1228.64
- Tangible Book Valueper Share Common Eq
- 11.88
- Period
- 2020
- Cashfrom Operating Activities
- 171.47
- Cashfrom Investing Activities
- 72.46
- Cashfrom Financing Activities
- -303.85
- Net Changein Cash
- -59.92
- Period
- 2019
- Total Revenue
- 1813.58
- Selling/ General/ Admin Expenses Total
- 506.24
- Depreciation/ Amortization
- 30.57
- Other Operating Expenses Total
- 19.16
- Total Operating Expense
- 1562.52
- Operating Income
- 251.06
- Net Income Before Taxes
- 243.03
- Net Income
- 205.09
- Diluted Normalized EPS
- 5.63
- Period
- 2019
- Total Assets
- 1942.28
- Total Liabilities
- 615.75
- Total Equity
- 1326.53
- Tangible Book Valueper Share Common Eq
- 14.54
- Period
- 2019
- Cashfrom Operating Activities
- 301.51
- Cashfrom Investing Activities
- 30.27
- Cashfrom Financing Activities
- -318.45
- Net Changein Cash
- 13.33
- Period
- 2018
- Total Revenue
- 1690.27
- Selling/ General/ Admin Expenses Total
- 479.55
- Depreciation/ Amortization
- 31.13
- Other Operating Expenses Total
- 23.31
- Total Operating Expense
- 1463.79
- Operating Income
- 226.48
- Net Income Before Taxes
- 240.73
- Net Income
- 186.07
- Diluted Normalized EPS
- 4.33
- Period
- 2018
- Total Assets
- 1978.95
- Total Liabilities
- 834.75
- Total Equity
- 1144.21
- Tangible Book Valueper Share Common Eq
- 9.66
- Period
- 2018
- Cashfrom Operating Activities
- 242.28
- Cashfrom Investing Activities
- -74.15
- Cashfrom Financing Activities
- -145.32
- Net Changein Cash
- 22.81
- Period
- 2024-12-31
- Total Revenue
- 704.45
- Selling/ General/ Admin Expenses Total
- 144.38
- Depreciation/ Amortization
- 14.28
- Other Operating Expenses Total
- 90.5
- Total Operating Expense
- 602.98
- Operating Income
- 101.47
- Net Income Before Taxes
- 113.84
- Net Income
- 87.41
- Diluted Normalized EPS
- 2.38
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 733.76
- Selling/ General/ Admin Expenses Total
- 141.73
- Depreciation/ Amortization
- 13.89
- Other Operating Expenses Total
- 88.1
- Total Operating Expense
- 609.2
- Operating Income
- 124.56
- Net Income Before Taxes
- 135.69
- Net Income
- 104.99
- Diluted Normalized EPS
- 2.86
- Period
- 2024-09-30
- Total Assets
- 2525.94
- Total Liabilities
- 639.86
- Total Equity
- 1886.08
- Tangible Book Valueper Share Common Eq
- 29.78
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 188.79
- Cashfrom Investing Activities
- 0.54
- Cashfrom Financing Activities
- -142.52
- Net Changein Cash
- 46.81
- Period
- 2024-06-30
- Total Revenue
- 741.81
- Selling/ General/ Admin Expenses Total
- 147.73
- Depreciation/ Amortization
- 13.41
- Other Operating Expenses Total
- 99.29
- Total Operating Expense
- 621.77
- Operating Income
- 120.04
- Net Income Before Taxes
- 132.37
- Net Income
- 101.73
- Diluted Normalized EPS
- 2.77
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 659.99
- Selling/ General/ Admin Expenses Total
- 132.31
- Depreciation/ Amortization
- 12.86
- Other Operating Expenses Total
- 85.98
- Total Operating Expense
- 564.47
- Operating Income
- 95.52
- Net Income Before Taxes
- 107.23
- Net Income
- 78.16
- Diluted Normalized EPS
- 2.13
- Period
- 2024-03-31
- Total Assets
- 2400.93
- Total Liabilities
- 592.62
- Total Equity
- 1808.31
- Tangible Book Valueper Share Common Eq
- 27.68
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 457.92
- Cashfrom Investing Activities
- -344.37
- Cashfrom Financing Activities
- -134.81
- Net Changein Cash
- -21.26
- Period
- 2023-12-31
- Total Revenue
- 677.5
- Selling/ General/ Admin Expenses Total
- 135.84
- Depreciation/ Amortization
- 12.83
- Other Operating Expenses Total
- 82.66
- Total Operating Expense
- 571.7
- Operating Income
- 105.8
- Net Income Before Taxes
- 115.2
- Net Income
- 90.89
- Diluted Normalized EPS
- 2.48
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 732.34
- Selling/ General/ Admin Expenses Total
- 134.3
- Depreciation/ Amortization
- 12.31
- Other Operating Expenses Total
- 90.74
- Total Operating Expense
- 609.28
- Operating Income
- 123.06
- Net Income Before Taxes
- 135.12
- Net Income
- 104.15
- Diluted Normalized EPS
- 2.84
- Period
- 2023-09-30
- Total Assets
- 2219.58
- Total Liabilities
- 580.34
- Total Equity
- 1639.24
- Tangible Book Valueper Share Common Eq
- 23.07
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 273.74
- Cashfrom Investing Activities
- -196.9
- Cashfrom Financing Activities
- -121.87
- Net Changein Cash
- -45.03
- Period
- 2023-06-30
- Total Revenue
- 687.1
- Selling/ General/ Admin Expenses Total
- 126.3
- Depreciation/ Amortization
- 11.96
- Other Operating Expenses Total
- 85.16
- Total Operating Expense
- 581.64
- Operating Income
- 105.46
- Net Income Before Taxes
- 121.29
- Net Income
- 96.29
- Diluted Normalized EPS
- 2.62
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 616.95
- Selling/ General/ Admin Expenses Total
- 110.34
- Depreciation/ Amortization
- 11.9
- Other Operating Expenses Total
- 80.46
- Total Operating Expense
- 537.59
- Operating Income
- 79.36
- Net Income Before Taxes
- 81.94
- Net Income
- 59.25
- Diluted Normalized EPS
- 1.62
- Period
- 2023-03-31
- Total Assets
- 2061.71
- Total Liabilities
- 512.72
- Total Equity
- 1548.99
- Tangible Book Valueper Share Common Eq
- 20.6
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 328.6
- Cashfrom Investing Activities
- -48.29
- Cashfrom Financing Activities
- -250.68
- Net Changein Cash
- 29.64
- Period
- 2022-12-31
- Total Revenue
- 612.67
- Selling/ General/ Admin Expenses Total
- 108.23
- Depreciation/ Amortization
- 12.16
- Other Operating Expenses Total
- 71.45
- Total Operating Expense
- 540.47
- Operating Income
- 72.2
- Net Income Before Taxes
- 84.25
- Net Income
- 67.39
- Diluted Normalized EPS
- 1.84
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Jyothy Labs Technical
Moving Average
SMA
- 5 Day384.97
- 10 Day379.58
- 20 Day357.28
- 50 Day357.68
- 100 Day377.81
- 300 Day447.93
Jyothy Labs Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Emami
- 623
- 3.3
- 0.53
- 859.2
- 438.05
- 27275.46
- Gillette India
- 8129.1
- -38.8
- -0.48
- 10652.1
- 6191
- 26617.24
- Jyothy Labs
- 382
- 5.9
- 1.57
- 595
- 268.05
- 14027.6
- Indiamart Intermesh
- 2242
- -4.95
- -0.22
- 3198.95
- 1850
- 13464
- Welspun Living
- 128.15
- 3.45
- 2.77
- 213.1
- 105
- 12291.54
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Emami
- 37.37
- 11.06
- 28.94
- 18.75
- Gillette India
- 63.18
- 27.4
- 36.1
- 14.45
- Jyothy Labs
- 38.57
- 7.65
- 15.81
- 10.14
- Indiamart Intermesh
- 40.74
- 7.76
- 20.47
- 32.63
- Welspun Living
- 17.66
- 2.68
- 13.8
- 6.21
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 31-Jan-25
- Quarterly Results
- 12-Nov-24
- Quarterly Results
- 25-Jul-24
- Quarterly Results
- 15-May-24
- Audited Results & Final Dividend
- 31-Jan-24
- Quarterly Results
- 07-Nov-23
- Quarterly Results
- 25-Jul-23
- Quarterly Results
- 03-May-23
- Audited Results & Final Dividend
- 25-Jan-23
- Quarterly Results
- 14-Nov-22
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 25-Jul-24
- 15-May-24
- AGM
- 11-Mar-24
- 06-Feb-24
- POM
- 25-Jul-23
- 03-May-23
- AGM
- 25-Jul-22
- 23-May-22
- AGM
- 10-May-22
- 08-Apr-22
- POM
- 30-Jul-21
- 18-May-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 15-May-24
- -
- 03-Jul-24
- 3.5
- 03-May-23
- -
- 03-Jul-23
- 3
- 24-May-22
- -
- 01-Jul-22
- 2.5
- 18-May-21
- -
- 20-Jul-21
- 4


